RMD: Leadership change · Company disclosure

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026. Mr. Taylor’s intention to retire is not due to any disagreement with Resmed on any matter relating to Resmed’s operations, policies or practices. In connection with Mr. Taylor’s retirement, the Board approved the appointment of Carol Burt as lead director, effective November 15, 2026. Item 7.01. Regulation FD Disclosure. On August 17, 2026, the Company issued a press release announcing the retirement of Mr. Taylor effective at the Annual Meeting and the appointment of Ms. Burt as lead director effective November 15, 2026. A copy of Resmed’s press release relating to these announcements is being furnished as Exhibit 99.1 to this current report on Form 8-K. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibits: Description of Document 16.1 Letter from KPMG LLP to the Securities and Exchange Commission, dated August 17, 2026. 99.1 Press Release, dated August 17, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL, document) 2 SIGNATURES We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934. Date: August 17, 2026 ResMed Inc. (registrant) By: /s/ Michael J. Rider Name: Michael J. Rider Its: Global General Counsel and Secretary